Literature DB >> 16207728

Understanding variation in measles-mumps-rubella immunization coverage--a population-based study.

James A Wright1, Clare Polack.   

Abstract

BACKGROUND: Coverage of the Measles-Mumps-Rubella combined vaccine (MMR) has declined in recent years in the UK, following adverse publicity about possible links between the vaccine, autism, and Crohn's disease. The objectives of this study were to assess geographical variation in trends in MMR coverage and to identify the factors affecting MMR uptake at population level.
METHODS: We conducted an ecological study of immunization coverage by second birthday, based on routinely collected data from 1993-2004 for England. Trends in MMR uptake were assessed in 95 District Health Authorities in England over the study period. We investigated the relationship between MMR immunization uptake and deprivation, ethnicity, education, population density, rurality, and socioeconomic class.
RESULTS: Since 2000, MMR coverage has declined significantly in virtually all areas of England. Population density and deprivation were both strongly correlated with low MMR uptake. The decline in coverage since 1993-94 was significantly related to the proportion of educated population and was greater in densely populated areas.
CONCLUSION: Decline in MMR coverage now affects most areas of England. The lowest rates of MMR coverage remain in urban areas, particularly in inner cities, which also tend to show high levels of deprivation. Public health resources should continue to target inner city areas, as well as focus on the concerns of the better educated about vaccine safety.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207728     DOI: 10.1093/eurpub/cki194

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  18 in total

1.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

Review 2.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

Review 3.  Accessing hard to reach groups, travelers and looked after children.

Authors:  Fiona Print
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

Review 4.  Public trust and vaccine acceptance--international perspectives.

Authors:  Sachiko Ozawa; Meghan L Stack
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

5.  The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan.

Authors:  Hajime Sato; Jun Tomio; Yoshiaki Tanaka; Emiko Iwasaki
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

6.  Vaccine waning and mumps re-emergence in the United States.

Authors:  Joseph A Lewnard; Yonatan H Grad
Journal:  Sci Transl Med       Date:  2018-03-21       Impact factor: 17.956

7.  Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem.

Authors:  C Stein-Zamir; G Zentner; N Abramson; H Shoob; Y Aboudy; L Shulman; E Mendelson
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

8.  Vaccination coverage and sociodemographic determinants of measles-mumps-rubella vaccination in three different age groups.

Authors:  Corinne Vandermeulen; Mathieu Roelants; Heidi Theeten; Pierre Van Damme; Karel Hoppenbrouwers
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

9.  Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study.

Authors:  Anna Pearce; Catherine Law; David Elliman; Tim J Cole; Helen Bedford
Journal:  BMJ       Date:  2008-02-28

10.  Exploring the relationship between population density and maternal health coverage.

Authors:  Michael Hanlon; Roy Burstein; Samuel H Masters; Raymond Zhang
Journal:  BMC Health Serv Res       Date:  2012-11-21       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.